Splicing variants of androgen receptor in prostate cancer. - Wikidata - awgldk - TriplyDB

Splicing variants of androgen receptor in prostate cancer.

Splicing variants of androgen receptor in prostate cancer.

http://www.wikidata.org/entity/Q34448143

about

Breast cancer molecular subtypes: from TNBC to QNBC Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer.Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes.Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression Interplay between Cytoplasmic and Nuclear Androgen Receptor Splice Variants Mediates Castration Resistance.

P2860

Q28076805-08C6F08E-8742-4ABB-8466-E9B14E107972 Q35604380-F5C3CD9C-C8CE-4EF9-9C3B-F3ACA6989373 Q35754996-E1C88BC1-C213-4F65-9A2F-086A04F86D45 Q36021859-BBCBA0D3-8D10-4A19-9C39-A80B2FD8C160 Q36796016-C97C4D16-0E41-4B2C-9702-4E0194D35E2F Q38743584-F145D2FA-7E56-41B9-9A01-7B6EA61B7371

P2860

Splicing variants of androgen receptor in prostate cancer.

http://www.wikidata.org/entity/Q34448143

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Splicing variants of androgen receptor in prostate cancer.

@ast

Splicing variants of androgen receptor in prostate cancer.

@en

Splicing variants of androgen receptor in prostate cancer.

@nl

type

label

Splicing variants of androgen receptor in prostate cancer.

@ast

Splicing variants of androgen receptor in prostate cancer.

@en

Splicing variants of androgen receptor in prostate cancer.

@nl

prefLabel

Splicing variants of androgen receptor in prostate cancer.

@ast

Splicing variants of androgen receptor in prostate cancer.

@en

Splicing variants of androgen receptor in prostate cancer.

@nl

P1433

Q34448143-53C67DD7-5F83-4F6D-AB83-C4923ECA093E

P1476

Q34448143-C5C9776E-BDC2-4D7C-9CFC-5FDC3348D5D7

P2093

Q34448143-1C1C1BAD-C980-4183-8EC6-27CBD7A1F8AB

Q34448143-7AC32309-F5BA-4A7A-BFE3-EA2BDEECB528

Q34448143-BF7B9887-C52E-4B7E-BEFB-ABA8617FBA1C

Q34448143-D14D2250-39AD-4245-85FF-E2742270C433

Q34448143-D4FCB789-CB04-4F81-9459-1B704B8C4B22

Q34448143-E081BC64-69EF-4956-A6AB-5EB5E0CF93F7

Q34448143-F6FB5F05-AF2A-4960-B43A-2F6FA06C0BA9

P2860

Q34448143-0F194000-5CB2-414A-85F7-12900419D34B

Q34448143-14C139C8-B480-4AAC-AA27-8313444C1EEB

Q34448143-27250F04-A4A0-4AFA-A54A-D19DAC8C18B3

Q34448143-29CC947D-33E6-4E77-ABC8-91C245C9FF7D

Q34448143-2A92A378-1AF3-4165-AD75-D18E49FCCF29

Q34448143-4563AA31-932B-42C5-9D08-6D89F1772567

Q34448143-4B79D9C0-132E-452E-A9E5-0F6734F4166E

Q34448143-522071E2-FC0D-453D-A500-BE0831374DFD

Q34448143-57AEFC6D-AB1D-42C5-8084-4CECE08577DA

Q34448143-6557ED6C-EF0B-498E-9403-8270749A5744

P304

Q34448143-32AC995D-D700-42AB-956C-98E46D23A23C

P31

Q34448143-AA56ADBD-3D24-4D92-8123-749436FA3DC8

P433

Q34448143-AD7E8590-18F5-4EF5-BE19-4BE3722878F7

P478

Q34448143-25059894-310F-4FDA-8A9F-9DB9C20A3187

P577

Q34448143-7050081A-E466-41FD-A0AF-71801340727C

P698

Q34448143-326CF47C-A126-4D84-867C-C12A3339F0DA

P932

Q34448143-4BA5B523-FF59-4261-86D7-82E9F292075A

P1433

American journal of clinical and experimental urology

P1476

Splicing variants of androgen receptor in prostate cancer

@en

P2093

Guanyi Zhang

http://www.w3.org/2001/XMLSchema#string

Haitao Zhang

http://www.w3.org/2001/XMLSchema#string

Oliver Sartor

http://www.w3.org/2001/XMLSchema#string

Xichun Liu

http://www.w3.org/2001/XMLSchema#string

Yan Dong

http://www.w3.org/2001/XMLSchema#string

Yanfeng Qi

http://www.w3.org/2001/XMLSchema#string

Yang Zhan

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival

Androgen receptor variants occur frequently in castration resistant prostate cancer metastases

Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor

Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

Increased survival with enzalutamide in prostate cancer after chemotherapy

Abiraterone and increased survival in metastatic prostate cancer

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression

P304

18-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25374896

http://www.w3.org/2001/XMLSchema#string

P932

4219285

http://www.w3.org/2001/XMLSchema#string